Bicara Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 05/15/2026 | 7.26 M | $144.32 M | 4.31% | 13.27% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 05/15/2026 | 6.61 M | $131.39 M | 104.10% | 12.08% |
| SIREN, L.L.C. | 05/14/2026 | 5.80 M | $115.42 M | 11.23% | 10.61% |
| VESTAL POINT CAPITAL, LP | 05/15/2026 | 5.43 M | $107.90 M | 51.75% | 9.92% |
| DEEP TRACK CAPITAL, LP | 05/15/2026 | 4.06 M | $80.80 M | 55.41% | 7.43% |
| JANUS HENDERSON GROUP PLC | 05/18/2026 | 3.34 M | $66.35 M | 26.19% | 6.11% |
| RED TREE MANAGEMENT, LLC | 04/22/2026 | 3.17 M | $63.06 M | 0.00% | 5.80% |
| TPG GP A, LLC | 05/15/2026 | 3.01 M | $59.88 M | 0.00% | 5.51% |
| BLACKROCK, INC. | 05/13/2026 | 2.84 M | $56.56 M | 12.47% | 5.20% |
| OMEGA FUND MANAGEMENT, LLC | 05/15/2026 | 2.39 M | $47.58 M | 8.50% | 4.38% |
| 05/14/2026 | 2.39 M | $46.69 M | 89.06% | 4.37% | |
| FMR LLC | 05/15/2026 | 2.10 M | $41.79 M | -37.23% | 3.84% |
| 05/15/2026 | 1.77 M | $35.29 M | 100.00% | 3.24% | |
| CITADEL ADVISORS LLC | 05/15/2026 | 1.66 M | $33.00 M | 114.87% | 3.03% |
| FRANKLIN RESOURCES INC | 05/13/2026 | 1.62 M | $32.25 M | 0.10% | 2.97% |
| STATE STREET CORP | 05/15/2026 | 1.42 M | $28.23 M | -13.95% | 2.60% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2026 | 1.38 M | $27.37 M | -11.76% | 2.52% |
| 05/14/2026 | 1.26 M | $25.06 M | 100.00% | 2.30% | |
| HEALTHINVEST PARTNERS AB | 05/11/2026 | 1.17 M | $2.32 M | 950.29% | 2.14% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 830.91 K | $16.53 M | 2.40% | 1.52% |
| FIL LTD | 05/15/2026 | 679.90 K | $13.52 M | -10.36% | 1.24% |
| ORBIMED ADVISORS LLC | 05/15/2026 | 667.30 K | $13.27 M | 219.13% | 1.22% |
| ACORN CAPITAL ADVISORS, LLC | 05/15/2026 | 643.38 K | $12.80 M | 0.00% | 1.18% |
| AISLING CAPITAL MANAGEMENT LP | 05/05/2026 | 568.92 K | $11.32 M | 0.00% | 1.04% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 558.96 K | $11.12 M | 1.20% | 1.02% |
| PALO ALTO INVESTORS LP | 05/15/2026 | 550.41 K | $10.95 M | 84.35% | 1.01% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 05/15/2026 | 489.10 K | $9.73 M | 13.98% | 0.89% |
| NAN FUNG TRINITY (HK) LTD | 05/05/2026 | 427.89 K | $8.51 M | 14.90% | 0.78% |
| DAFNA CAPITAL MANAGEMENT LLC | 05/15/2026 | 421.73 K | $8.39 M | 61.22% | 0.77% |
| MORGAN STANLEY | 05/15/2026 | 421.22 K | $8.38 M | 284.83% | 0.77% |
| ENSIGN PEAK ADVISORS, INC | 05/13/2026 | 401.44 K | $7.98 M | 0.00% | 0.73% |
| ALGERT GLOBAL LLC | 05/14/2026 | 330.83 K | $6.58 M | 3.95% | 0.61% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 327.99 K | $6.52 M | -2.29% | 0.60% |
| 05/08/2026 | 290.94 K | $5.79 M | 100.00% | 0.53% | |
| CLEARBRIDGE INVESTMENTS, LLC | 05/13/2026 | 289.22 K | $5.75 M | -3.19% | 0.53% |
| D. E. SHAW & CO., INC. | 05/15/2026 | 276.94 K | $5.51 M | 102.86% | 0.51% |
| TD ASSET MANAGEMENT INC | 05/11/2026 | 269.72 K | $5.36 M | 10.26% | 0.49% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 263.99 K | $5.25 M | -3.00% | 0.48% |
| NORTHERN TRUST CORP | 05/14/2026 | 255.57 K | $5.08 M | 7.79% | 0.47% |
| CANDRIAM S.C.A. | 04/30/2026 | 238.82 K | $4.75 M | 100.00% | 0.44% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 05/13/2026 | 233.70 K | $4.65 M | 55.80% | 0.43% |
| WOODLINE PARTNERS LP | 05/15/2026 | 232.69 K | $4.63 M | 0.00% | 0.43% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 216.75 K | $4.31 M | 100.00% | 0.40% |
| UBS GROUP AG | 05/05/2026 | 179.49 K | $3.57 M | -6.61% | 0.33% |
| JPMORGAN CHASE & CO | 05/13/2026 | 177.41 K | $3.38 M | 953.05% | 0.32% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 156.70 K | $3.12 M | -63.95% | 0.29% |
| DEUTSCHE BANK AG\ | 05/06/2026 | 131.66 K | $2.62 M | 2.36% | 0.24% |
| NAPEAN TRADING & INVESTMENT CO (SINGAPORE) PTE LTD | 05/12/2026 | 113.78 K | $2.26 M | 0.00% | 0.21% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 109.26 K | $2.17 M | 166.92% | 0.20% |
| WALLEYE CAPITAL LLC | 05/13/2026 | 108.01 K | $2.15 M | 100.00% | 0.20% |
Bicara Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 169 institutional investors and hedge funds held shares of Bicara Therapeutics Inc.. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 7.26 M
T. Rowe Price Investment Management, Inc.: 6.61 M
Siren, L.L.C.: 5.8 M
Vestal Point Capital, LP: 5.43 M
Deep Track Capital, LP: 4.06 M
JANUS HENDERSON GROUP PLC: 3.34 M
130.33% of Bicara Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 67.92 M shares in the last 24 months. This purchase volume represents approximately $1.34 B in transactions.